Our 2023 Health Care Business Panel looked at the top threats and opportunities in health care right now. The panelists covered the business outlook and dealmaking recalibration that is taking place in the health care industry, the regulatory power of the Biden administration and how they are looking to change health care, as well as antitrust issues, drug imports, telemedicine, generative AI and learnings from COVID-19.
Mike King, shareholder at Brownstein Hyatt Farber Schreck
Nadeam Elshami, policy director at Brownstein Hyatt Farber Schreck
Alex Geier, managing director at GLC Advisors & Co.
Deema Tarazi, senior policy advisor and counsel at Brownstein Hyatt Farber Schreck
This document is intended to provide you with general information regarding the business of health care. The contents of this document are not intended to provide specific legal advice. If you have any questions about the contents of this document or if you need legal advice as to an issue, please contact the attorneys listed or your regular Brownstein Hyatt Farber Schreck, LLP attorney. This communication may be considered advertising in some jurisdictions. The information in this article is accurate as of the publication date.